EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Alpha 3

Ensembl ID : ENSPTIG00000004401
Gene Symbol: ATP1A3
2 Cross references
134 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSPTIG00000008397
Gene Symbol: ATP1B1
1 Cross references
295 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSPTIG00000021917
Gene Symbol: ATP1B2
1 Cross references
274 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSPTIG00000018572
Gene Symbol: ATR
2 Cross references
206 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSPTIG00000004013
Gene Symbol: AXL
2 Cross references
197 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPTIG00000021440
Gene Symbol: BRAF
1 Cross references
220 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSPTIG00000003217
Gene Symbol: BCL2
2 Cross references
227 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSPTIG00000004882
Gene Symbol: BCL2L1
2 Cross references
286 Possible Orthologues:

Bcl2 Like 2

Ensembl ID : ENSPTIG00000000034
Gene Symbol: BCL2L2
2 Cross references
64 Possible Orthologues:

Bcl2 Related Protein A1

Ensembl ID : ENSPTIG00000021256
Gene Symbol: BCL2A1
2 Cross references
114 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSPTIG00000017250
Gene Symbol: BCR
2 Cross references
274 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSPTIG00000017399
Gene Symbol: BTK
2 Cross references
207 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).